Skip to main content

MTUS2 Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77130PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-77130PEP

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

A blocking peptide containing 18 amino acids near the carboxy terminus of human CAZIP.

Source: Synthetic

(Accession #: NP_001028774)

Purity

N/A

Application Notes

This peptide is useful as a blocking peptide for NBP1-77130. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-77130PEP
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
Preservative 0.02% Sodium Azide
Concentration 0.2 mg/ml
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: MTUS2

MTUS2 binds microtubules. Together with MAPRE1 may target the microtubule depolymerase KIF2C to the plus-end of microtubules. May regulate the dynamics of microtubules at their growing distal tip

Alternate Names

Cardiac zipper protein, CAZIPTracking protein of 150 kDa, KIAA0774+TIP of 150 kDa, microtubule associated tumor suppressor candidate 2, Microtubule plus-end tracking protein TIP150, TIP150microtubule-associated tumor suppressor candidate 2

Gene Symbol

MTUS2

Additional MTUS2 Products

Product Documents for MTUS2 Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for MTUS2 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...